Transforming Growth Factor Beta2 Promotes Migration and Inhibits the Proliferation of Gastric Cancer Cells by Regulating the pSmad2/3-NDRG1 Signaling Pathway.
Saved in:
| Title: | Transforming Growth Factor Beta2 Promotes Migration and Inhibits the Proliferation of Gastric Cancer Cells by Regulating the pSmad2/3-NDRG1 Signaling Pathway. |
|---|---|
| Authors: | He FJ; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China.; Department of Thyroid and Breast Surgery West China School of Public Health and West China Fourth Hospital Chengdu China., Chen XL; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China., Zhu YF; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China., Pang HY; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China., Li ZD; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China., Liang PP; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China., Jin T; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China.; West China School of Medicine West China Hospital Sichuan University Chengdu China., Chen ZW; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China., Chen ZH; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China.; West China School of Medicine West China Hospital Sichuan University Chengdu China., Hu JK; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China., Yang K; Department of General Surgery & Laboratory of Gastric Cancer State Key Laboratory of Biotherapy Collaborative Innovation Center of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu China.; Gastric Cancer Center West China Hospital，Sichuan University Chengdu China. |
| Source: | MedComm [MedComm (2020)] 2025 Mar 27; Vol. 6 (4), pp. e70148. Date of Electronic Publication: 2025 Mar 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2688-2663 |
|---|---|
| DOI: | 10.1002/mco2.70148 |
